NF1 deficiency drives metabolic reprogramming in ER+ breast cancer

Objective: NF1 is a tumor suppressor gene and its protein product, neurofibromin, is a negative regulator of the RAS pathway. NF1 is one of the top driver mutations in sporadic breast cancer such that 27 % of breast cancers exhibit damaging NF1 alterations. NF1 loss-of-function is a frequent event i...

Full description

Saved in:
Bibliographic Details
Main Authors: Rachel (Rae) (Author), Elizabeth A. Tovar (Author), Luke N. Redlon (Author), Curt J. Essenburg (Author), Patrick S. Dischinger (Author), Abigail E. Ellis (Author), Ian Beddows (Author), Ryan D. Sheldon (Author), Evan C. Lien (Author), Carrie R. Graveel (Author), Matthew R. Steensma (Author)
Format: Book
Published: Elsevier, 2024-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available